A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma

BACKGROUND: The current management guidelines recommend that patients with borderline resectable pancreatic adenocarcinoma (BRPC) should initially receive neoadjuvant chemotherapy. The addition of advanced radiation therapy modalities, including stereotactic body radiation therapy (SBRT) and intraop...

Descripción completa

Detalles Bibliográficos
Autores principales: Paiella, Salvatore, Malleo, Giuseppe, Simoni, Nicola, Micera, Renato, Guariglia, Stefania, Cavedon, Carlo, Marchegiani, Giovanni, Esposito, Alessandro, Landoni, Luca, Casetti, Luca, Tuveri, Massimiliano, Milella, Michele, Secchettin, Erica, Manzini, Gessica, Bovo, Chiara, De Pastena, Matteo, Fontana, Martina, Salvia, Roberto, Mazzarotto, Renzo, Bassi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885611/
https://www.ncbi.nlm.nih.gov/pubmed/33593311
http://dx.doi.org/10.1186/s12885-021-07877-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885611/
https://www.ncbi.nlm.nih.gov/pubmed/33593311
http://dx.doi.org/10.1186/s12885-021-07877-7

Ejemplares similares